CLINICAL_TRIALS
trial_result
· 2026-03-20
Clinical Trial Update: Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus [Phase 2]
Summary
This Phase 2 long-term safety and efficacy study of deucravacitinib in systemic lupus erythematosus has completed data collection and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2026-03-20